UK Medtech's Gateway To Regulatory Opportunity Is Open – But For How Long?
MHRA issues guidance on GB standstill extension and EU MDR/IVDR transitions aide-memoire
Executive Summary
The pace of activity in medtech circles as the UK government and MHRA target a robust-but-agile regulatory system for Great Britain has been fairly relentless. Manufacturers serving the British medtech markets eye the plans and promises with patience – for now at least.